会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 11. 发明授权
    • Effective nuclear reprogramming in mammals using CDK2 inhibitors
    • 使用CDK2抑制剂对哺乳动物进行有效的核重编程
    • US06906238B2
    • 2005-06-14
    • US09809662
    • 2001-03-15
    • Steven Stice
    • Steven Stice
    • C12N15/873C12N15/00A01K67/027C12N5/02
    • C12N15/873
    • The present invention provides methods of producing a cloned non-human mammalian nuclear transfer (NT) embryo and methods for producing a cloned non-human mammal. Embodiments of the methods include introducing donor genetic material into a metaphase I oocyte; introducing donor genetic material into a non-enucleated oocyte; introducing donor genetic material obtained from a donor cell that is at metaphase into an oocyte; introducing donor genetic material into an oocyte, and naturally activating the oocyte or the NT embryo; and introducing donor genetic material obtained from a donor cell that is at late G1 phase into an oocyte.
    • 本发明提供了产生克隆的非人哺乳动物核转移(NT)胚胎的方法和用于产生克隆的非人哺乳动物的方法。 方法的实施方案包括将供体遗传物质引入中期卵母细胞; 将供体遗传物质引入非去核卵母细胞; 将从中期的供体细胞获得的供体遗传物质引入卵母细胞; 将供体遗传物质引入卵母细胞,并自然激活卵母细胞或NT胚胎; 并将从晚期G1期的供体细胞获得的供体遗传物质引入卵母细胞。